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n t t h e d i s t r i b u t i o n s of t h e expected values. T h u s , %r p a t i e n t s w i t h low or m o d e r a t e cancer ~rades,
t h e large a m o u n t of overlap s u g g e s t s decision a p p e a r s to be a t o s s -u p ; clinically t h i s m a k e s s e n s e to me. Also, I w o n d e r ff the more a p p r o p r i a t e l n e a s u r e is the distribuUon of t h e difference in expected v a l u e b e t w e e n sm-.~e~ a n d watctfful waiting, ~A N I E L J , In repty:--We appreciate the thorou._Chness w i t h w h i c h Dr.
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Cher read ore-paper, He a p p e a r s to raise t h r e e importaxlt i s s u e s , First, re.ffardtn~ Table 3 , t h e 95% confidence i n t e r v a l s do n o t b o u n d t h e Monte Carlo i n p u t p a r a m e t e r s . Rather, t h e y help to define the s h a p e of t h e d i s t r i b u t i o n u s e d %r sa~zzpltn~ by tndieat in~ w h e r e m u c h of t h e d a t a lie.
Dr. Cher's second major p o i n t c o n c e r n s t h e boxplots of Figu r e 3 , w h i c h m a y be c a u s i n g confusion. These boxplots have medians, s u n -o t m d e d by a n o t c h e d a r e a denotin~ the 95% eonfi denee interval %r t h e m e d i a n , wtzteh itseK is s u r r o u n d e d by t h e i n t e r q u a r t i l e r a n g e (the box), a n d finally t h e d a t a r a n g e (marked by wtztskers), Ore-conce~zl a b o u t s t a t i s t i c a l si.~zificaxzee w a s t h a t a p3-eater n u m b e r of s i m u l a t i o n r t m s would r e s u l t itz n a r r o w e r confidence i n t e r v a l s a r o u n d each m e d i a n , i n c r e a s i n g the likelihood of detecting differences due to nonoverlapping" confidence intervals. We were not i n t e r e s t e d i n deteettn.~ small differences b e t w e e n t r e a t m e n t s (p. 301), Medians r a t h e r t t~ m e a n s were fl l u s t r a t e d due to t h e nonnolTnally d i s t r i b u t e d data in m a n y of t h e boxplots in Fi.g~re 3.
His ttztrd major point eoneel~S fllustrattn.~ t r e a t m e n t differ e n c e s r a t h e r t h a n i n d i v i d u a l t r e a t m e n t effectiveness separately. A n a l y s i s of t h e differences o b t a i n e d in e a c h s i m u l a t i o n r u n w o u l d indeed be more s t a t i s t i c a l l y powerful b e c a u s e t h e t r e a t m e n t eova riax~ee w o u l d be m a i n t a i n e d , Ut~ortLmately, ore-Markov modelin~ software does not a u t o m a t i c a l l y provide t h a t level of detail for t h e
r e s u l t s of second-order Monte Carlo simulations. However, we were able to do one of t h e s c e n a r i o s m a n u a l l y , also w i t h 67 model r u n s . We selected t h e cohort w i t h the l e a s t difference in t r e a t m e n t benefit: t h e cohort of 75-year-old m e n w i t h well-differentiated cancer. The boxplot of t h e t r e a t m e n t benefit %r r a d i c a l pros t a t e c t o m y a p p e a r s in Fieza-e 1, p r e s e n t e d here. This r e s u l t a.p3-ees w i t h t h a t in t h e oti_~nal m a n u s c r i p t : r a d i c a l p r o s t a t e c t o m y provided 0.3 QALYs of benefit. If t h e t r e a t m e n t decision is a t o s s -u p , ore-boxplots failed to i l l u s t r a t e it. In a n y case, a decision ax~alysis s u c h as om-s provides very little ~n i d a n c e in the mana.~ement of t h e i n d i v i d u a l p r o s t a t e cancer patient. , University a n d Woodland A v e n u e s , Philadelphia. PA 19104; fax: 215-823-4450 ; e maih jgim@matl.med.upenn.edu.. 
